MarketPeel
Insider Trading Intelligence
Pricing
…
BH

Beth Hecht

ITRM
DIRECTOR · ITERUM THERAPEUTICS PLC · CIK 0001652410
FILING MIX · LIFETIME44%/56%
BUYS
28
SELLS
35
TOTAL VALUE
$3.51M
COMPANIES
3
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
1,189,019
AVG SELL PX
$4.87
TRADE KIND
SHOWING 63 / 63
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 23 pending
Forward-return performance of every backtestable P/S trade by Beth Hecht, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+54.55%-2.81%-1.23%-1.58%-1.48%—
14d11+45.45%-4.76%-1.75%-3.01%-4.17%—
30d11+36.36%-10.33%-3.03%-8.14%-6.35%—
60d11+36.36%+1.64%+0.72%+0.89%-0.67%—
90d11(1 pending)+60.00%+4.25%+2.25%+2.48%-10.94%—
180d11(5 pending)+50.00%+17.82%+12.61%+10.78%-1.55%—
1y11(8 pending)+66.67%+60.10%+27.52%+32.58%+52.53%—
2y11(9 pending)+50.00%-14.01%+47.04%-61.04%-61.04%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ITRM · 18,839 shares · as of Jun 15, 2023
059,449118,898178,346237,79520222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 28 buys / 35 sellsCOVERAGE · 28 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,666$8.03$133.9K1,161,128Jul 1, 2026Jul 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$6.06$101.0K1,176,506Jun 1, 2026Jun 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$6.23$103.8K1,193,173May 1, 2026May 1, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$5.99$99.9K1,209,840Apr 1, 2026Apr 3, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,567$6.24$103.4K1,226,607Mar 2, 2026Mar 4, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
100$7.06$7061,226,507Mar 2, 2026Mar 4, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
16,667$7.45$124.1K1,243,174Feb 2, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
98,375$7.36$724.0K1,331,021Jan 31, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
46,914$7.36$345.3K1,284,107Jan 31, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
24,266$7.36$178.6K1,259,841Jan 31, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
121,293——1,429,396Jan 30, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
162,162——162,162Jan 30, 2026Feb 2, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$7.43$123.8K1,308,103Jan 2, 2026Jan 5, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$7.01$116.8K1,320,176Dec 1, 2025Dec 2, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,667$7.40$123.3K1,336,843Nov 11, 2025Nov 13, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
40,000$5.43$217.2K1,353,510Mar 20, 2025Mar 21, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
185,000——1,393,510Jan 31, 2025Feb 3, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
300,000——300,000Jan 31, 2025Feb 3, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
98,375$3.56$350.2K1,208,510Jan 31, 2025Feb 3, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
45,909$3.56$163.4K1,306,885Jan 31, 2025Feb 3, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
32,039$3.61$115.7K1,352,794Jan 3, 2025Jan 7, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
750,000——1,554,968Jan 31, 2024Jan 31, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
45,909$2.46$112.9K1,380,802Jan 31, 2024Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
19,675$2.66$52.3K1,426,711Jan 29, 2024Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
33,488$2.24$75.0K1,446,386Jan 3, 2024Aug 9, 2024 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
SALE
15,853——0Jun 15, 2023Jun 15, 2023 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASE
15,853——18,839Jun 15, 2023Jun 15, 2023 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
350,000——797,758Jan 31, 2023Feb 1, 2023 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
5,784$1.24$7.2K1,479,874Jan 31, 2023Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
21,177$1.26$26.7K1,485,658Jan 29, 2023Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
33,488$1.12$37.5K1,506,835Jan 3, 2023Aug 9, 2024 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
SALE
36,798——0Jun 23, 2022Jun 24, 2022 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASE
36,798——44,805Jun 23, 2022Jun 24, 2022 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
237,795$0.01$2.4K237,795Jun 15, 2022Jun 17, 2022 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
SALE
7,642——0Mar 18, 2022Mar 22, 2022 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASE
7,642——8,007Mar 18, 2022Mar 22, 2022 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
4,448$2.11$9.4K1,540,323Jan 31, 2022Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
14,037$2.11$29.6K1,544,771Jan 29, 2022Aug 9, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
225,000——436,821Jan 3, 2022Jan 5, 2022 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
32,500——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
3,826——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
180,000——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
150,000——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
65,295——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
26,366——180,000Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
See Remarks
30,879——0Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
26,366——26,366Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
180,000——206,366Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,826——3,826Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
65,295——65,295Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
32,500——32,500Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
30,879——30,879Oct 5, 2021Oct 5, 2021 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
36,798——36,798Jun 23, 2021Jun 25, 2021 ↗View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
6,500——9,052Apr 8, 2021Apr 12, 2021 ↗View →
ITRM
ITERUM THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
7,642——7,642Mar 18, 2021Mar 19, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
150,000——210,814Jan 29, 2021Feb 1, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Aug 14, 2020Aug 17, 2020 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,731$2.26$8.4K60,814Jun 30, 2020Jul 15, 2020 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASE
See Remarks
4,000$1.97$7.9K57,083Mar 13, 2020Mar 16, 2020 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASE
See Remarks
4,000$4.15$16.6K8,083Feb 14, 2020Feb 18, 2020 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
45,000——53,083Jan 31, 2020Mar 2, 2020 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
459$5.99$2.7K4,083Dec 31, 2019Jan 6, 2020 ↗View →
Other insiders · ITRM
Loading peer insiders…
About this filer
CIK 0001652410
ROLE
Director
PRIMARY
ITRM
COMPANIES
3
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001652410DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback